The extracellular DNA lattice of bacterial biofilms is structurally related to Holliday junction recombination intermediates.
Aishwarya DevarajJohn R BuzzoLauren Mashburn-WarrenErin S GloagLaura A NovotnyPaul StoodleyLauren O BakaletzSteven D GoodmanPublished in: Proceedings of the National Academy of Sciences of the United States of America (2019)
Extracellular DNA (eDNA) is a critical component of the extracellular matrix of bacterial biofilms that protects the resident bacteria from environmental hazards, which includes imparting significantly greater resistance to antibiotics and host immune effectors. eDNA is organized into a lattice-like structure, stabilized by the DNABII family of proteins, known to have high affinity and specificity for Holliday junctions (HJs). Accordingly, we demonstrated that the branched eDNA structures present within the biofilms formed by NTHI in the middle ear of the chinchilla in an experimental otitis media model, and in sputum samples recovered from cystic fibrosis patients that contain multiple mixed bacterial species, possess an HJ-like configuration. Next, we showed that the prototypic Escherichia coli HJ-specific DNA-binding protein RuvA could be functionally exchanged for DNABII proteins in the stabilization of biofilms formed by 3 diverse human pathogens, uropathogenic E. coli, nontypeable Haemophilus influenzae, and Staphylococcus epidermidis Importantly, while replacement of DNABII proteins within the NTHI biofilm matrix with RuvA was shown to retain similar mechanical properties when compared to the control NTHI biofilm structure, we also demonstrated that biofilm eDNA matrices stabilized by RuvA could be subsequently undermined upon addition of the HJ resolvase complex, RuvABC, which resulted in significant biofilm disruption. Collectively, our data suggested that nature has recapitulated a functional equivalent of the HJ recombination intermediate to maintain the structural integrity of bacterial biofilms.
Keyphrases
- candida albicans
- biofilm formation
- escherichia coli
- pseudomonas aeruginosa
- cystic fibrosis
- extracellular matrix
- single molecule
- circulating tumor
- staphylococcus aureus
- cell free
- binding protein
- end stage renal disease
- dna damage
- endothelial cells
- dna repair
- newly diagnosed
- ejection fraction
- mycobacterium tuberculosis
- peritoneal dialysis
- risk assessment
- high resolution
- patient safety
- chronic kidney disease
- multidrug resistant
- circulating tumor cells
- big data
- pluripotent stem cells
- air pollution
- human health
- life cycle
- type iii